These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31579950)

  • 1. The effect of eplerenone on the renin-angiotensin-aldosterone system of rats with thyroid dysfunction.
    Dizaye K; Mustafa ZA
    J Pharm Pharmacol; 2019 Dec; 71(12):1800-1808. PubMed ID: 31579950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aliskiren, Fosinopril, and Their Outcome on Renin-Angiotensin-Aldosterone System (RAAS) in Rats with Thyroid Dysfunction.
    Farhadi SAS; Dizaye KF
    Int J Endocrinol; 2019; 2019():5960563. PubMed ID: 31396276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of eplerenone on cerebral aldosterone levels and brain lesions in spontaneously hypertensive rats.
    Wang X; Zhu Y; Wang S; Wang Z; Sun H; He Y; Yao W
    Clin Exp Hypertens; 2020 Aug; 42(6):531-538. PubMed ID: 32020810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin-aldosterone system in hyper- and hypothyroid rats during sodium depletion.
    Montiel M; Jiménez E; Narváez JA; Morell M
    Endocr Res Commun; 1982-1983; 9(3-4):249-60. PubMed ID: 7188049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system in thyroid dysfunction in rats.
    Marchant C; Brown L; Sernia C
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):449-55. PubMed ID: 7504137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division.
    Vecchiola A; Fuentes CA; Solar I; Lagos CF; Opazo MC; Muñoz-Durango N; Riedel CA; Owen GI; Kalergis AM; Fardella CE
    Front Endocrinol (Lausanne); 2020; 11():223. PubMed ID: 32373073
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum angiotensin I converting enzyme activity in patients with hyperthyroidism and hypothyroidism: relation to renin and aldosterone].
    Gotoh M; Mizuno K; Matsui J; Kunii N; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1984 Jul; 60(7):835-45. PubMed ID: 6094273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of the renin-angiotensin system to blood pressure variability in hyperthyroid rats].
    Basset A; Blanc J; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):905-10. PubMed ID: 10989728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone and plasma renin activity in hyperthyroid rats: effects of propranolol and propylthiouracil.
    Montiel M; Jiménez E; Naváez JA; Morell M
    J Endocrinol Invest; 1984 Dec; 7(6):559-62. PubMed ID: 6397501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in plasma homocysteine levels of rats with experimentally induced hypothyroidism and hyperthyroidism.
    Ozkan Y; Dönder E; Güney H; Baydaş G
    Neuro Endocrinol Lett; 2005 Oct; 26(5):536-40. PubMed ID: 16264404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Responses of plasma bradykinin and the renin angiotensin axis to angiotensin II in hyperthyroid patients].
    Takeda Y; Miyamori I; Ikeda M; Koshida H; Yasuhara S; Morise T; Okamoto S; Kawato M; Takeda R
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):61-8. PubMed ID: 3009241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hyper- and hypothyroidism on the basal levels of angiotensin I and kinetic parameters of renin-angiotensin system in male rats.
    Jiménez E; Montiel M; Narváez JA; Morell M
    Rev Esp Fisiol; 1982 Jun; 38(2):149-54. PubMed ID: 7122971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of two different experimental situations of hypothyroidism on serum aldosterone concentration and plasma renin in rats.
    Montiel M; Jiménez E; Narváez JA; Ruiz M; Morell M
    Rev Esp Fisiol; 1984 Dec; 40(4):431-6. PubMed ID: 6397794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of single treatment with the antihypertensive drug eplerenone on hormone levels and anxiety-like behaviour in rats.
    Hlavacova N; Jezova D
    Endocr Regul; 2008 Sep; 42(4):147-53. PubMed ID: 18999902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum angiotensin-converting enzyme and plasma atrial natriuretic peptide levels in hyperthyroid and hypothyroid rabbits.
    Yeğin E; Yiğitoğlu R; Ari Z; Celik I; Akçay F; Süzek H
    Jpn Heart J; 1997 Mar; 38(2):273-9. PubMed ID: 9201114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of mineralocorticoid receptor blockade with direct renin inhibition in angiotensin II-dependent hypertensive mice.
    Hashimoto A; Takeda Y; Karashima S; Kometani M; Aono D; Demura M; Higashitani T; Konishi S; Yoneda T; Takeda Y
    Hypertens Res; 2020 Oct; 43(10):1099-1104. PubMed ID: 32398797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of inhibition of renin-angiotensin-aldosterone system components in hypertensive rats given salt excess.
    Susic D; Varagic J; Frohlich ED
    Am J Physiol Heart Circ Physiol; 2010 Apr; 298(4):H1177-81. PubMed ID: 20118410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
    Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eplerenone inhibits the intracrine and extracellular actions of angiotensin II on the inward calcium current in the failing heart. On the presence of an intracrine renin angiotensin aldosterone system.
    De Mello WC; Gerena Y
    Regul Pept; 2008 Nov; 151(1-3):54-60. PubMed ID: 18585409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine and cardiac paracrine actions of insulin-like growth factor-I (IGF-I) during thyroid dysfunction in the rat: is IGF-I implicated in the mechanism of heart weight/body weight change during abnormal thyroid function?
    Thomas MR; Miell JP; Taylor AM; Ross RJ; Arnao JR; Jewitt DE; McGregor AM
    J Mol Endocrinol; 1993 Jun; 10(3):313-23. PubMed ID: 8373515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.